ConductScience.org, home

Paper9768753

Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors.

Valés-Gómez M and 3 others. Immunity, 1998. Cited by 101 papers, by iCite.

Cite this record

ConductScience Library. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. Papers, record 9768753. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9768753

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors.
PubMed
Journal
Immunity
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
101
iCite
Relative citation ratio, by iCite
1.77
iCite
Revised in PubMed
2019-09-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Valés-Gómez MM
2Reyburn HTH T
3Mandelboim MM
4Strominger JLJ L

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HLA-C AntigensMajor topic
Receptors, ImmunologicMajor topic
Biosensing Techniques
Killer Cells, Natural
Kinetics
Ligands
Receptors, KIR
Recombinant Proteins
Solubility
Temperature

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA-4774NCI NIH HHSUnited StatesPubMed

Source PubMed

Download CSV of grants

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.

PMIDTitleJournalYearIn PapersSource
39511139Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39511139PubMed
38185735Structural basis for the activity and specificity of the immune checkpoint inhibitor lirilumab.Sci Rep2024https://conductscience.org/library/papers/38185735PubMed
37403548The genotype list string code syntax for exchanging nomenclature-level genotyping results in clinical and research data management and analysis systems.HLA2023https://conductscience.org/library/papers/37403548PubMed
37286192Genotype List String 1.1: Extending the Genotype List String grammar for describing HLA and Killer-cell Immunoglobulin-like Receptor genotypes.HLA2023https://conductscience.org/library/papers/37286192PubMed
36974156The Association between Deoxyribonucleic Acid Hypermethylation in Intron VII and Human Leukocyte Antigen-C∗07 Expression in Patients with Endometriosis.Int J Clin Pract2023https://conductscience.org/library/papers/36974156PubMed
36574700KIR signaling is regulated by electrostatic interaction of its cytosolic tail with the plasma membrane despite being neutral polyampholyte.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/36574700PubMed
33923528Current Perspectives on the Use of off the Shelf CAR-T/NK Cells for the Treatment of Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/33923528PubMed
31337191
Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study
Turk J Haematol2019https://conductscience.org/library/papers/31337191PubMed
28916655Tethering IL2 to Its Receptor IL2Rβ Enhances Antitumor Activity and Expansion of Natural Killer NK92 Cells.Cancer Res2017https://conductscience.org/library/papers/28916655PubMed
28649982Structural and regulatory diversity shape HLA-C protein expression levels.Nat Commun2017https://conductscience.org/library/papers/28649982PubMed
28352266Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C.Front Immunol2017https://conductscience.org/library/papers/28352266PubMed
26874942Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies.Cancer Immunol Immunother2016https://conductscience.org/library/papers/26874942PubMed
26594216Effector Functions of Natural Killer Cell Subsets in the Control of Hematological Malignancies.Front Immunol2015https://conductscience.org/library/papers/26594216PubMed
26088726The limits of chemosensation vary across dimensions.Nat Commun2015https://conductscience.org/library/papers/26088726PubMed
25960307Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant2015https://conductscience.org/library/papers/25960307PubMed
24797174The activating Ly49W and inhibitory Ly49G NK cell receptors display similar affinities for identical MHC class I ligands.Immunogenetics2014https://conductscience.org/library/papers/24797174PubMed
24209843Dynamics of natural killer cell receptor revealed by quantitative analysis of photoswitchable protein.Biophys J2013https://conductscience.org/library/papers/24209843PubMed
23849068Genotype List String: a grammar for describing HLA and KIR genotyping results in a text string.Tissue Antigens2013https://conductscience.org/library/papers/23849068PubMed
23677581Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR.Eur J Immunol2013https://conductscience.org/library/papers/23677581PubMed
22752190Killer cell immunoglobulin-like receptor (KIR) gene content variation in the HGDP-CEPH populations.Immunogenetics2012https://conductscience.org/library/papers/22752190PubMed

See all 43 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
KIR2DL13802PubTator's text mininghttps://conductscience.org/library/genes/3802NCBI Gene
KIR2DL33804PubTator's text mininghttps://conductscience.org/library/genes/3804NCBI Gene
KIR2DS13806PubTator's text mininghttps://conductscience.org/library/genes/3806NCBI Gene
TACR16869PubTator's text mininghttps://conductscience.org/library/genes/6869NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9768753

GET https://conductscience.org/api/papers/v1/9768753/cited_by?page=2